Stocks and Investing
Stocks and Investing
Wed, June 2, 2021
[ 12:00 AM ] - WOPRAI
Tue, June 1, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Charles Duncan Maintained (BHVN) at Buy with Increased Target to $140 on, Jun 1st, 2021
Charles Duncan of Cantor Fitzgerald, Maintained "Biohaven Ltd." (BHVN) at Buy with Increased Target from $125 to $140 on, Jun 1st, 2021.
Charles has made no other calls on BHVN in the last 4 months.
There are 4 other peers that have a rating on BHVN. Out of the 4 peers that are also analyzing BHVN, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $69 on, Tuesday, May 18th, 2021
These are the ratings of the 3 analyists that currently disagree with Charles
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $92 on, Friday, May 28th, 2021
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $105 on, Wednesday, May 12th, 2021
- Esther Rajavelu of "UBS" Initiated at Strong Buy and Held Target at $108 on, Thursday, March 11th, 2021
Contributing Sources